A novel ETV6::FGFR1 fusion gene in a myeloid/lymphoid neoplasm with FGFR1 rearrangement sensitive to specific FGFR1-2-3 inhibition-Reference-Cited by-同舟云学术

A novel ETV6::FGFR1 fusion gene in a myeloid/lymphoid neoplasm with FGFR1 rearrangement sensitive to specific FGFR1-2-3 inhibition

Published:2023-12-20 Issue: Volume: Page:1-5
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Jiménez-Vicente Carlos¹,Garrote Marta²³^ORCID,López-Guerra Mónica²³⁴,Villamón Eva⁵,Guijarro Francesca²³,Perez-Valencia Amanda Isabel¹,Martinez-Roca Alexandra¹²,Balaguer Olga⁶,Álvarez-Larrán Alberto¹³^ORCID,Hernández-Boluda Juan Carlos⁵,Rovira Montserrat¹³,Colomer Dolors²³,Diaz-Beyá Marina¹²³,Rozman Maria²,Esteve Jordi¹³

Affiliation:

1. Hematology Department, Hospital Clínic of Barcelona, Barcelona, Spain

2. Hematopathology Unit, Pathology Department, Hospital Clinic of Barcelona, Barcelona, Spain

3. Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain

4. Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain

5. Hospital Clínico Universitario-INCLIVA, University of Valencia, Valencia, Spain

6. Pathology Department, Hospital Clinic of Barcelona, Barcelona, Spain

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2023.2295788

Reference15 articles.

1. Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC; 2017.

2. Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT

3. A new myeloproliferative disorder associated with chromosomal translocations involving 8p11: a review;Macdonald D;Leukemia,1995

4. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms

5. Fibroblast growth factor receptor fusions in cancer: opportunities and challenges;Chen L;J Exp Clin Cancer Res,2021